Related Experiment Videos
Enzyme-amplified rate conductimetric immunoassay
J C Thompson1, J A Mazoh, A Hochberg
1E. I. Du Pont de Nemours and Company, Inc., Medical Products, Newark, Delaware.
Analytical Biochemistry
|May 1, 1991
Summary
This study introduces a novel conductimetric immunoassay for detecting human chorionic gonadotropin. The method uses urease enzyme and measures conductance changes, achieving sensitive detection of the protein biomarker.
Area of Science:
- Biotechnology
- Analytical Chemistry
- Biosensor Technology
Background:
- Immunoassays are crucial for detecting biomarkers.
- Existing methods can be complex and costly.
- A need exists for simplified, cost-effective immunoassay platforms.
Purpose of the Study:
- To develop and validate a new conductimetric immunoassay technique.
- To utilize urease enzyme for enhanced signal generation.
- To detect human chorionic gonadotropin (hCG) in serum samples.
Main Methods:
- An immobilized monoclonal antibody captured the protein analyte.
- A second antibody, conjugated to urease enzyme, was used.
- Conductance changes in solution were measured to quantify analyte-bound enzyme.
- Urea was used as the substrate for the urease enzyme.
Main Results:
- The assay successfully detected human chorionic gonadotropin (hCG) in serum.
- A detection limit of 30 picomolar was achieved with a 30-second measurement.
- Urease enzyme demonstrated high activity and stability under assay conditions.
- Observed conductance changes aligned with theoretical predictions.
Conclusions:
- Conductimetric immunoassay offers a sensitive and potentially cost-effective detection method.
- The technique shows promise for developing simplified biosensor devices.
- Further optimization could lead to even lower detection limits for biomarkers.